Microvascular invasion as a predictor of disease progression in prostate cancer.

被引：0
|
作者：
Herman, CM [1 ]
Wilcox, GE [1 ]
Kattan, MW [1 ]
Scardino, PT [1 ]
Wheeler, TM [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：84A / 84A
页数：1
相关论文
共 50 条
  • [41] A novel predictor of clinical progression in patients on active surveillance for prostate cancer
    Tan, Guan Hee
    Finelli, Antonio
    Ahmad, Ardalan
    Wettstein, Marian S.
    Chandrasekar, Thenappan
    Zlotta, Alexandre R.
    Fleshner, Neil E.
    Hamilton, Robert J.
    Kulkarni, Girish S.
    Ajib, Khaled
    Nason, Gregory
    Perlis, Nathan
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (08): : 250 - 255
  • [42] immunoPET for imaging disease progression in prostate cancer
    Rebecca Kelsey
    Nature Reviews Urology, 2014, 11 (12) : 661 - 661
  • [43] Effect of obesity on PSA density (PSAD): A new clinical predictor of prostate cancer.
    Garzotto, M.
    Mongoue-Tchokote, S.
    Shannon, J.
    Peters, L.
    Sokoloff, M. H.
    Beer, T. M.
    Mori, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 245S - 245S
  • [44] CRISP3 expression drives prostate cancer invasion and progression
    Volpert, Marianna
    Furic, Luc
    Hu, Jinghua
    O'Connor, Anne E.
    Rebello, Richard J.
    Keerthikumar, Shivakumar
    Evans, Jemma
    Merriner, D. Jo
    Pedersen, John
    Risbridger, Gail P.
    McIntyre, Peter
    O'Bryan, Moira K.
    ENDOCRINE-RELATED CANCER, 2020, 27 (07) : 415 - 430
  • [45] E-cadherin and associated molecules in the invasion and progression of prostate cancer
    Davies, G
    Jiang, WG
    Mason, MD
    ONCOLOGY REPORTS, 1998, 5 (06) : 1567 - 1576
  • [46] MDSC clinical assay for disease surveillance in prostate cancer.
    Chang, Grace
    Kang, Irene
    Shahabi, Ahva
    Nadadur, Malini
    Athreya, Kanthi
    Suer, Evren
    Canter, David
    Chen, Mo-Li
    Martin, Sue Ellen
    Aron, Monish
    Groshen, Susan G.
    Epstein, Alan L.
    Pinski, Jacek K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [47] VASCULAR LYMPHATIC INVASION IN PROSTATE-CANCER CORRELATES WITH PATTERNS OF PROGRESSION
    SALOMAO, D
    GRAHAM, S
    BOSTWICK, DG
    LABORATORY INVESTIGATION, 1993, 68 (01) : A68 - A68
  • [48] Atherornatous disease and latent prostate cancer. A correlation or a coincidence
    Stamatiou, Konstantinos N.
    Alevizos, Alevizos G.
    Natzar, Mohamad A.
    Karakoukis, Nikolaos G.
    Mariolis, Anargiros D.
    Sofras, Fragiskos A.
    SAUDI MEDICAL JOURNAL, 2006, 27 (05) : 746 - 747
  • [49] Management of prostate cancer. Part 3: metastatic disease
    Shah, Jyoti
    Khakar, Sara Jane
    Sooriakumaran, Prasanna
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (05) : 813 - 821
  • [50] Evaluation of microvascular invasion as a prognostic factor in the progression of non-metastatic renal cancer
    Bengio, Ruben G.
    Cristian Arribillaga, Leandro
    Epelde, Javier
    Orellana, Sergio
    Montedoro, Ariel
    Bengio, Veronica
    Cordero, Esteban
    Guevara, Matias
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2018, 71 (04) : 386 - 390
12345